Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The update changes the displayed ClinicalTrials.gov page revision number from v3.5.2 to v3.5.3, reflecting a tooling/interface release rather than a modification to the trial record data.
    Difference
    0.1%
    Check dated 2026-04-24T06:44:11.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now listed, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:55:42.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A new version entry was added to the Record History, reflecting updates to the study record such as status, design, eligibility, and contacts/locations.
    Difference
    0.1%
    Check dated 2026-04-09T21:50:31.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision history shows the addition of v3.5.0 and the removal of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:05:15.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Record History shows the addition of Revision: v3.4.3 and the deletion of Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:36:12.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding-notice block along with the prior Revision: v3.4.1 entry.
    Difference
    0.8%
    Check dated 2026-02-11T14:18:48.000Z thumbnail image

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.